Friday, 30 April 2021
AstraZeneca Makes $275 Million in Sales from Covid-19 Vaccine
AstraZeneca's Covid-19 jab was developed with the University of Oxford and has been key in Britain's rapid vaccination drive. The company is selling it at cost price.
from Top Business News- News18.com
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
AstraZeneca's Covid-19 jab was developed with the University of Oxford and has been key in Britain's rapid vaccination drive. The company is selling it at cost price.
No comments:
Post a Comment